Abstract
Synthego, a four-year-old genome engineering tools firm, has raised $41 million in a Series B funding round. Investors include the technology venture firms 8VC and AME Cloud Ventures, backed by Yahoo founder Jerry Yang. Jennifer Doudna, a UC Berkeley professor and CRISPR/Cas9 pioneer, also invested. Synthego provides synthetic RNA sequences critical for employing CRISPR technology. The company was founded by former SpaceX engineers Paul and Michael Dabrowski.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
